Literature DB >> 16172426

Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.

Stephen J Duffy1, Elizabeth S Biegelsen, Robert T Eberhardt, David F Kahn, Bronwyn A Kingwell, Joseph A Vita.   

Abstract

Recent studies suggest that hypertension associated with low renin status and hyperaldosteronism is associated with increased risk for end-organ damage and cardiovascular events compared with other forms of hypertension. Additionally, experimental studies have demonstrated impaired nitric oxide-mediated bioactivity in these states. To investigate the relation between renin/aldosterone status and resistance vessel function, we examined plasma renin activity, serum aldosterone level, and forearm blood flow responses to the endothelium-dependent vasodilator methacholine and the endothelium-independent vasodilators sodium nitroprusside and verapamil using venous occlusion plethysmography in 130 volunteers (43 hypertensive, 87 normotensive). Low renin status was associated with impaired responses to methacholine and nitroprusside in patients with hypertension. Peak methacholine response was 8.7+/-5.6 mL/min per dL in the lowest renin quartile (0.1 to 0.3 ng/mL per hour) versus 14.3+/-7.3 mL/min per dL in the highest 3 renin quartiles combined (0.4 to 4.6 ng/mL per hour; P<0.001). Peak nitroprusside response was 5.6+/-2.3 mL/min per dL in the lowest renin quartile versus 13.3+/-4.1 mL/min per dL in the highest 3 renin quartiles combined (P<0.001). Blood pressure and other clinical characteristics were similar in all 4 quartiles. Vasodilator responses to verapamil did not relate to renin activity. Methacholine and nitroprusside responses did not relate to renin status in normotensive controls (P=0.34). Importantly, hypertensive patients with a high aldosterone/renin ratio also had impaired responses to methacholine. This study demonstrates that low-renin hypertension is associated with marked impairment of nitric oxide-mediated vasodilation of resistance vessels in the forearm vasculature of humans. This impairment could contribute to adverse outcomes in patients with low-renin hypertension and relative aldosterone excess.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172426      PMCID: PMC2737344          DOI: 10.1161/01.HYP.0000184231.84465.62

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  44 in total

1.  Are ACE inhibitors a "magic bullet" against oxidative stress?

Authors:  T Münzel; J F Keaney
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Prognostic significance of endothelial dysfunction in hypertensive patients.

Authors:  F Perticone; R Ceravolo; A Pujia; G Ventura; S Iacopino; A Scozzafava; A Ferraro; M Chello; P Mastroroberto; P Verdecchia; G Schillaci
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

4.  NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat.

Authors:  R A Beswick; A M Dorrance; R Leite; R C Webb
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

5.  Salt sensitivity, pulse pressure, and death in normal and hypertensive humans.

Authors:  M H Weinberger; N S Fineberg; S E Fineberg; M Weinberger
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

6.  Endothelial dysfunction in salt-sensitive essential hypertension.

Authors:  E Bragulat; A de la Sierra; M T Antonio; A Coca
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

7.  Iron chelation improves endothelial function in patients with coronary artery disease.

Authors:  S J Duffy; E S Biegelsen; M Holbrook; J D Russell; N Gokce; J F Keaney; J A Vita
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

Review 8.  Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension.

Authors:  A Ergul
Journal:  Hypertension       Date:  2000-07       Impact factor: 10.190

Review 9.  New perspectives on the role of aldosterone excess in cardiovascular disease.

Authors:  M Stowasser
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-10       Impact factor: 2.557

10.  Endothelial function during stimulation of renin-angiotensin system by low-sodium diet in humans.

Authors:  T Omland; W Johnson; M B Gordon; M A Creager
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

View more
  14 in total

1.  Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.

Authors:  Kristen L Nowak; Berenice Gitomer; Heather Farmer-Bailey; Wei Wang; Mikaela Malaczewski; Jelena Klawitter; Zhiying You; Diana George; Nayana Patel; Anna Jovanovich; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2019-02-23       Impact factor: 8.860

Review 2.  Effect of excessive salt intake: role of plasma sodium.

Authors:  Stefan Reuter; Eckhart Büssemaker; Martin Hausberg; Hermann Pavenstädt; Uta Hillebrand
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

3.  Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.

Authors:  Takeshi Matsumoto; Kenji Oki; Masato Kajikawa; Ayumu Nakashima; Tatsuya Maruhashi; Yumiko Iwamoto; Akimichi Iwamoto; Nozomu Oda; Takayuki Hidaka; Yasuki Kihara; Nobuoki Kohno; Kazuaki Chayama; Chikara Goto; Yoshiki Aibara; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  Hypertension       Date:  2015-01-26       Impact factor: 10.190

4.  Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.

Authors:  Shinji Kishimoto; Kenji Oki; Tatsuya Maruhashi; Masato Kajikawa; Shogo Matsui; Haruki Hashimoto; Yuji Takaeko; Yasuki Kihara; Kazuaki Chayama; Chikara Goto; Yoshiki Aibara; Farina Mohamad Yusoff; Ayumu Nakashima; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

Review 5.  Vascular endothelial function and hypertension: insights and directions.

Authors:  Kodlipet Dharmashankar; Michael E Widlansky
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

6.  Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.

Authors:  Hans Oberleithner; Christoph Riethmüller; Hermann Schillers; Graham A MacGregor; Hugh E de Wardener; Martin Hausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

7.  Sex Differences and COVID-19.

Authors:  Natalie Thomas; Caroline Gurvich; Jayashri Kulkarni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats.

Authors:  Andreas M Beyer; Katherine Fredrich; Julian H Lombard
Journal:  Am J Hypertens       Date:  2013-08-09       Impact factor: 2.689

9.  The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.

Authors:  M Tzanela; G Effraimidis; G Effremidis; D Vassiliadi; A Szabo; N Gavalas; A Valatsou; E Botoula; N C Thalassinos
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

10.  Renin-angiotensin-aldosterone system gender differences in an Afro-Caribbean population.

Authors:  Damian H Cohall; Thea Scantlebury-Manning; Stephen James; Kiana Hall; Carlos M Ferrario
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-02-14       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.